Study uncovers potential new target for treatment of chronic, debilitating skin disease

Psychedelics proven to reduce depression. Clinical trial shows 100% of participants responsive to treatment, 71% in remission after 12 months and only 2 doses.

New research shows that the anti-anxiety and hallucinogenic-like effects of a psychedelic drug work through different neural circuits. The study, in a mouse model, shows that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.

Study uncovers earliest evidence of humans using fire to shape the landscape of Tasmania - EurekAlert